Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type Versus Mutated Proteins

ISRN Oncology
doi 10.1155/2013/536529
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Mutant and Wild-Type Ras: Co-Conspirators in Cancer

Cancer Discovery
Oncology
2013English

Targeting Oncogenic Ras

Genes and Development
GeneticsDevelopmental Biology
2007English

Multiple Conformations of Activated Ras Observed Directly by Single Molecule FRET

Seibutsu Butsuri
2003English

Differences in the Regulation of K-Ras and H-Ras Isoforms by Monoubiquitination

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

Targeting K-Ras Cancers

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Oncogenic and Wild-Type Ras Play Divergent Roles in the Regulation of Mitogen-Activated Protein Kinase Signaling

Cancer Discovery
Oncology
2012English

Ras Signaling Through RASSF Proteins

Seminars in Cell and Developmental Biology
Developmental BiologyCell Biology
2016English

One Step Closer to Targeting RAS

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2015English

Ras-Dependent and -Independent Pathways Target the Mitogen-Activated Protein Kinase Network in Macrophages.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy